Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAXAGLIPTIN vs SECNIDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAXAGLIPTIN vs SECNIDAZOLE: Safety Overview

Metric SAXAGLIPTIN SECNIDAZOLE
Total FAERS Reports 2,468 245
Deaths Reported 263 1
Death Rate 10.7% 0.4%
Hospitalizations 838 10
Average Patient Age 65.5 yrs 40.4 yrs
% Female Patients 47.8% 95.6%
FDA Approval Date Jul 31, 2009 Sep 15, 2017
Manufacturer Glenmark Pharmaceuticals Inc., USA Evofem Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription